|
|
|
|
|
-
Tuesday, December 2, 2025
|
|
|
|
|
| Press Releases |
|
 |
|
| Tuesday, December 2, 2025 |
|
|
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases |
| GEN Pharmaceuticals (GENIL.IS), Turkiye's leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class, novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. more info >> |
|
| Monday, July 28, 2025 |
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases |
| more info >> |
|
| Wednesday, September 25, 2024 |
|
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis |
| GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating the safety and efficacy of its investigational drug, GN-037 topical cream, in treating mild to moderate plaque psoriasis. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Dec 2, 2025 13:00 HKT/SGT
|
|
|
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 2, 2025 12:22 HKT/SGT
|
|
|
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 1, 2025 23:04 JST
|
|
|
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 1, 2025 22:43 JST
|
|
|
GMG Launches Pre-Order Sales for First to Market Multi Language THERMAL-XR(R) Kit with Electric Spray Gun
Dec 1, 2025 21:29 HKT/SGT
|
|
|
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 1, 2025 22:14 JST
|
|
|
HashKey Passes HKEX Hearing: From Asia's Compliance Pioneer to a Global Institutional Gateway for Digital Assets
Dec 1, 2025 18:39 HKT/SGT
|
|
|
AcroMeta Announces Strategic Joint Venture to provide AI-Powered Global Trade Operating System
Dec 1, 2025 18:20 HKT/SGT
|
|
|
FG Gold, AFC and Afreximbank Reach Financial Close on US$330 Million Senior Debt Financing for Baomahun Gold Project
Dec 1, 2025 17:09 HKT/SGT
|
|
|
China Chunlai Announces 2025 Annual Results
Dec 1, 2025 09:53 HKT/SGT
|
|
|
USDKG launching: $50M Gold-backed Stablecoin in the Kyrgyz Republic 
Nov 29, 2025 23:00 HKT/SGT
|
|
|
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
|
|
|
Capital Revo Expands Trader Education Framework Amid Rising 2025 User Engagement
Nov 28, 2025 22:00 HKT/SGT
|
|
|
Eternal Beauty Holdings Announces First Results Since Listing, Interim Profit for FY2025/2026 Increased 15.3% YoY to RMB 1.3 Million
Nov 28, 2025 20:12 HKT/SGT
|
|
|
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
| Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
Connect With us:
|
|
| |
